Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Accumulated Expenses (2016 - 2021)

Marimed (MRMD) has disclosed Other Accumulated Expenses for 8 consecutive years, with $2000.0 as the latest value for Q4 2021.

  • Quarterly Other Accumulated Expenses fell 91.54% to $2000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2021, down 91.54% year-over-year, with the annual reading at $2000.0 for FY2021, 91.54% down from the prior year.
  • Other Accumulated Expenses for Q4 2021 was $2000.0 at Marimed, down from $23640.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.6 million in Q1 2020, with the low at $2000.0 in Q4 2021.
  • Average Other Accumulated Expenses over 4 years is $713560.1, with a median of $541588.0 recorded in 2017.
  • Peak annual rise in Other Accumulated Expenses hit 660.32% in 2020, while the deepest fall reached 97.25% in 2020.
  • Over 4 years, Other Accumulated Expenses stood at $225000.0 in 2017, then skyrocketed by 281.41% to $858176.0 in 2019, then plummeted by 97.25% to $23640.0 in 2020, then plummeted by 91.54% to $2000.0 in 2021.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $2000.0, $23640.0, and $1.5 million for Q4 2021, Q4 2020, and Q3 2020 respectively.